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Objectives: Biocides are widely used to prevent infection. We aimed to determine whether exposure of
Salmonella to various biocides could act as a driver of antibiotic resistance.
Methods: Salmonella enterica serovar Typhimurium was exposed to four biocides with differing modes of action.
Antibiotic-resistant mutants were selected during exposure to all biocides and characterized phenotypically and
genotypically to identify mechanisms of resistance.
Results: All biocides tested selected MDR mutants with decreased antibiotic susceptibility; these occurred
randomly throughout the experiments. Mutations that resulted in de-repression of the multidrug efflux pump
AcrAB-TolC were seen in MDR mutants. A novel mutation in rpoA was also selected and contributed to the
MDR phenotype. Other mutants were highly resistant to both quinolone antibiotics and the biocide triclosan.
Conclusions: This study shows that exposure of bacteria to biocides can select for antibiotic-resistant mutants
and this is mediated by clinically relevant mechanisms of resistance prevalent in human pathogens.
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Introduction
Antibiotic resistance is one of the great global challenges facing
modern medicine.1,2 Pathogenic bacteria are commonly isolated
that are resistant to multiple classes of therapeutically important
antibiotics and, in some cases, pan-resistant strains have arisen for
which no conventional treatment remains effective.3–5 Antibiotic
resistance can occur as a result of antibiotics exerting selective
pressure leading to expansion of strains with resistancemutations
or those that have acquired resistance genes via horizontal gene
transfer.6,7 Classical experiments demonstrating the selection of
antibiotic-resistant mutants have focused on antibiotic exposures
to identify mutants with high-level resistance, often as a result of
alterations in genes encoding the antibiotic target.8 However,
recently it has become apparent that prolonged exposure of
bacteria to antibacterial agents at concentrations below those
required to arrest growth can also select for antibiotic-resistant
strains. Exposure to low concentrations of drug is significant
as the window of time and drug concentrations where selective
pressure is exerted is much larger than in conventional experi-
ments, where bacteria are exposed to lethal concentrations of
antibiotic and only highly resistant strains can survive. When
exposed to low concentrations of antibacterial, the number of
potential target genes for which mutation may be beneficial
and confer decreased susceptibility to antibiotics is much larger
than the complement of genes that may be able to confer
high-level resistance if mutated.9,10 Importantly, such exposure
regimes allow multiple generations of bacteria to compete
under low selective pressure, and this allows selection of epistatic
combinations of mutations in individual strains. Individually, such
mutations may have a low impact on antibiotic activity, but in
combination they may have greater effects as a result of synergy.
This also allows compensatory mutations to evolve in concert
with resistance mutations and so minimize any fitness costs
resulting from resistance.11
Prevention of infection is of paramount importance as the
outcomes of infection with an antibiotic-resistant bacterial
strain are often more severe than those of infections with anti-
biotic-susceptible strains.12 Biocides (disinfectants) are crucial to
successful infection control and are widely used in hospitals, on
farms, in the food industry and in the home for the control of
microorganisms.13,14 Biocides are often mixtures of active agents
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that exhibit high toxicity against target organisms. As a result, it is
difficult for bacteria to become resistant to the recommended
in-use concentrations of many biocides as mutation within a sin-
gle genewill not usually confer resistance. However, there are sev-
eral examples where bacteria have become biocide resistant or
show decreased susceptibility to biocides; some major mechan-
isms of antibiotic resistance are also relevant to bacterial survival
of biocide challenge.15 Amongst these, MDR efflux systems can
export both antibiotics and many biocides. Growth as a biofilm
can also dramatically reduce the efficacy of biocide activity.16,17
Exposure of bacteria to biocides can select for mutants with
decreased biocide susceptibility and, as we and others have
seen, these mutants often display a decrease in susceptibility to
various antibiotics, indicating that biocides can act as drivers of
antibiotic resistance under laboratory conditions.15,18 –20 Many
common biocides are now detectable in the environment and
some, such as triclosan, have been found in human urine,
serumand breastmilk.21–24Exposure to antibiotics in the environ-
ment can result in the selection of antibiotic-resistant bacteria,
which are a recognized reservoir of potential infection for humans
via contamination of foodstuffs, water and surfaces with resistant
pathogenic bacteria.25,26 The accumulation of biocides in the
environment (and in vegetables and other food materials)27,28
also represents a potentially prolonged, low-level stress, which
could exert selective pressure towards selection of bacteria with
decreased biocide susceptibility, which could be cross-resistant
to antibiotics. The possible results of such selective pressure are
currently uncertain.
To identify the consequences of exposure of bacteria to
low levels of biocide and whether there are any implications for
selection of antibiotic resistance, we investigated the impact of
exposure to low levels of four biocides representing different
active classes on antibiotic resistance and bacterial fitness of
Salmonella enterica serovar Typhimurium. We also used genome
sequencing to determine the genetic basis for the observed resist-
ance phenotypes.
Methods
Biocides and antibiotics
Four biocides representing classes with active ingredients belonging to dif-
ferent functional groups were chosen for use in the study: Superkill (AFS
Animal Care, UK) is a mixture of aldehydes and quaternary ammonium
compounds; AQAS (DuPont Animal Health) is a quaternary ammonium
compound; Virkon (DuPont Animal Health) is an oxidative compound;
and Trigene (Medichem International, UK) is a halogenated tertiary
amine compound.
Isolation of antibiotic-resistant mutants after exposure
to biocide
S. enterica serovar Typhimurium strain SL1344 was the parental strain
used in all experiments, representing both a pathogen and a model
Gram-negative bacterium. To determine the impact of repeated, low-level
exposure to biocides, SL1344 was exposed to biocides at sub-lethal con-
centrations that restricted growth rates to 70% of those in drug-free
media. Therefore, Superkill and AQAS were both added to media at a con-
centration of 0.0018%, Trigene at 0.0005% and Virkon at 0.2%. Overnight
cultures of SL1344 grown in LB broth at 378Cwith shaking at 150 rpmwere
used to inoculate fresh, pre-warmed broth (50 mL into 5 mL) containing
biocide. After 12 h of growth, a 1 mL sample was taken and stored in gly-
cerol at 2208C and 50 mL was used to inoculate fresh media containing
the same concentration of biocide (the second sub-culture). The bacterial
cultures were repeatedly sub-cultured over 4 days (total of eight sub-
cultures) in each biocide. Sampling was every 12 h to allow each culture
to reach stationary phase before sub-culture to fresh media. A total of
50 generations were passaged in each experiment. In parallel to the bio-
cide exposure experiments, SL1344 was also sub-cultured eight times in
LB broth with no biocide as a control. The eight frozen samples from
each biocide exposure experiment and the control experiment were seri-
ally diluted and inoculated onto antibiotic-free LB agar; after overnight
incubation, these plates (with 200 colonies each) were replica plated
onto LB agar plates, each containing a different antimicrobial at a concen-
tration that inhibited growth of SL1344. Nalidixic acid was used at 8 mg/L,
chloramphenicol at 4 mg/L, tetracycline at 4 mg/L, kanamycin at 8 mg/L
and triclosan at 0.12 mg/L. After overnight incubation, colonies that
grew on one or more of the antimicrobial-containing plates were selected
from the original antibiotic-free LB master plate, their identity confirmed
using the API 20E test (bioMe´rieux, France) and retained for further
investigation.
Phenotypic characterization of antibiotic-resistant
mutants
The antimicrobial susceptibility ofmutants resistant to one ormore agents
after exposure to biocide was determined for five antibiotics and five bio-
cides using a panel of antibiotics and the standardized agar dilution
method following the recommendations of the BSAC.29 Susceptibility to
antibiotics and biocides was also determined after five passages in drug-
free media to determine whether selected resistances were stable. The
phenotype of the mutants in Biolog Phenomicroarray antimicrobial plates
(PM11-20) was determined in duplicate and compared with that of
SL1344. Data were analysed for significant differences in both replicates
at multiple timepoints and in at least two sequential concentrations of
test compound.
The growth rates of selected mutants were compared with that of the
parental strain SL1344 by measuring the OD of cultures at 600 nm in a
FLUOstar Optima reader (BMG Labtech) as previously described.30 The fit-
ness costs of any of the selected mutations were evaluated in competitive
index experiments by introducing SL1344 and mutants into LB broth in
equal numbers and comparing the ratios of mutant to parent over time
as previously described.30 To determine whether any mutants had
changes in cellular morphology, cells of each mutant were Gram stained
and visualized under a microscope.
WGS and SNP detection
From each of the biocide exposure experiments, four drug-resistant
mutants representing the range of phenotypes were selected for sequen-
cing. Mutants were selected to reflect those that emerged early and
late in the selection period. Genomic DNA was extracted from 5 mL over-
night cultures grown in drug-free LB media using a Promega Wizardw
Genomic DNA Purification Kit. The quantity and quality of the DNA was
confirmed by agarose gel electrophoresis and by analysis using a
NanoDrop Spectrophotometer (Life Technologies) and Bioanalyzer (Life
Technologies). Mutants were sequenced using a 454 GS FLX instrument
(Roche) with Titanium chemistry and the resulting sequence reads
were mapped against the SL1344 reference genome using the
gsMapper alignment module of Newbler, run through the xBASE-NG web
site. High-confidence SNPs were identified as previously described.31
Mutations detected consistently in all sequenced isolates were deemed
to be differences between our WT laboratory strain and the sequenced
SL1344 reference strain and were excluded from further analysis.
Mutations and SNPs identifiedwere verified by PCR and Sanger sequencing.
Webber et al.
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Complementation of mutated genes with WT in trans
and site-directed mutagenesis
The coding sequences of the WT rpoA and zur genes were amplified from
SL1344 and cloned into a pBADmyc-HisA expression vector (Invitrogen)
to create pBAD-rpoA and pBAD-zur, respectively. The plasmid pBAD-zur
was transformed into the Trigene-selected mutants and the plasmid
pBAD-rpoA was transformed into AQAS-selected mutants. Induction of
expression of each genewaswith 0.05% arabinose. RT–PCR, using primers
internal to the WT gene, confirmed expression of the complements within
the mutants. Site-directed mutagenesis was used to recreate the rpoA
and zur changes found in the biocide exposure experiments, primers
were designed to amplify the mutations found within these genes
and mutagenesis was accomplished using the Red/ET recombinase kit
(GeneBridges, UK) according to the manufacturer’s instructions.
Results
Biocides select antibiotic-resistant bacteria
Independent cultures of WT Salmonella Typhimurium SL1344
were repeatedly sub-cultured in subinhibitory concentrations of
four biocides (Virkon, Trigene, AQAS and Superkill) with different
chemistries and modes of action. Samples were taken regularly
from each lineage andmutants with altered antibiotic susceptibil-
ity were identified using antibiotic indicator breakpoint plates con-
taining concentrations of antibiotic that restrict growth of SL1344.
Nomutants that were retained demonstrated increased tolerance
to the biocides they were exposed to, but, from as early as the
second sub-culture (although this varied between biocides), all
biocides selectedmutants with altered susceptibility to antibiotics
(Figure 1). Exposure of SL1344 to Superkill selected bacteria able
to grow on plates containing nalidixic acid, chloramphenicol and
tetracycline; further mutants arose sporadically throughout sub-
cultures 2–8. During exposure to AQAS, bacteria able to grow on
the antibiotic-containing plates were not seen until sub-culture
5. After this time, mutants were consistently recovered from the
analagous set of antibiotic-containing plates as for the Superkill
experiment. Sub-culture in Trigene resulted in selection of bacteria
able to grow in the presence of nalidixic acid and/or triclosan
from sub-culture 2 onwards; mutants with this phenotype
were detected for the remainder of the experiment. In the pres-
ence of Virkon, antibiotic-resistant strains appeared on various
antibiotic-containing plates after sub-culture 2; these were then
detected sporadically throughout sub-cultures 2–8.
All colonies identified as having decreased susceptibility to any
of the antibiotics tested were retained from the drug-free master
plate and the MICs of a panel of drugs were determined (Table S1,
available as Supplementary data at JAC Online).
The susceptibility of the majority of the Superkill and AQAS
mutants (SK1, SK3, SK4, AQ2, AQ4 and AQ5) to antibiotics and bio-
cides was similar and showed broad, decreased susceptibility to
drugs of different classes (Table 1). Mutants AQ1 and SK7 had a
different phenotype with decreased susceptibility to single anti-
biotics only. Mutants derived after exposure to Virkon demon-
strated two phenotypes: resistance to quinolones and resistance
to the biocide triclosan. In contrast, the mutants derived from
Trigene were phenotypically identical; all mutants were highly
quinolone resistant and resistant to triclosan.
Based on the phenotypes, four mutants from each biocide
challenge experiment were selected for genome sequencing.
The mutants were selected from a range of early and late sub-
cultures to investigate whether mutations that occurred early in
the selection period were maintained and whether multiple
mutations accumulated during the experiments (Table 1).
Biocide exposure selected mutations in only seven genes
In the mutants sequenced, seven genes were found to contain
mutations (Table 2). Five genes were altered in more than one
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Figure 1. Comparison of mutant selection between sub-culture and
biocide. (a) Number of mutants identified at each sub-culture. (b) Number
of mutants identified after exposure to each biocide. (c) Identification of
mutants per sub-culture by biocide.
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of the mutants, and mutations in three genes (fabI, ramR and
gyrA) were selected after exposure to multiple biocides. The four
AQAS mutants all carried an SNP in rpoA, encoding the RNA poly-
merase a subunit. Three of the AQASmutants also hadmutations
in ramR, which encodes the local repressor of ramA, encoding
a transcriptional activator that regulates the AcrAB-TolC
MDR efflux system. Two of these mutants carried a 2 bp deletion
within ramR and the other carried a point mutation resulting
in a substitution within the DNA-binding domain of RamR. The
remaining AQAS mutant, AQ1, also had a mutation in hpaA,
a gene that codes for a putative AraC family regulatory protein.
Of the four Superkill mutants selected for sequencing, three
carried a 12 nt deletion in ramR, but for the other (SK7) insufficient
depth of sequence was achieved to confidently identify
mutations.
All four Trigene mutants contained identical mutations in fabI
(encoding FabI, which is involved in fatty acid biosynthesis and is
the target site of triclosan). The substitution identified has previ-
ously been shown to confer triclosan resistance.32 The Trigene
mutants also contained a 2 bp insertionwithin zur, which encodes
a putative regulatory protein controlling zinc uptake systems. The
Trigene mutants also contained a point mutation within gyrA
encoding the a-subunit of DNA gyrase; the resulting substitution
is known to confer quinolone resistance.33 The same gyrA
mutation was also seen in both mutants selected after Virkon
exposure that were quinolone resistant. The other two mutants,
V4 and V8, both carried the same mutation in fabI as seen in
the Trigene-selected mutants. Finally, one Virkon-selected
mutant, V4, also carried a deletion within avtA encoding an
alanine–valine transaminase.
The mutations identified in ramR, gyrA and fabI have all
been extensively characterized by ourselves and others.30,32,34
However, there were also some novel mutations in genes not pre-
viously associated with susceptibility to antimicrobials; these
included the rpoA mutation, seen in all the AQAS mutants, and
the mutation within zur, seen in all the Trigene mutants.
The impact of the rpoA and zurmutations on antibiotic suscep-
tibility in those mutants with changes in these genes were inves-
tigated both by recreating these mutations in SL1344 and by
restoring the WT alleles of these genes in trans. A WT copy of
rpoA was introduced into mutants AQ1, AQ2, AQ4 and AQ5 on
plasmid pBADmyc-HisA. In the same way, a WT copy of zur was
introduced into T2, T3, T6 and T9. Transcription of both genes
was confirmed by RT–PCR and found to be similar to WT levels.
When mutations were recreated in SL1344, the mutation within
zur had no impact on antibiotic susceptibility and the rpoAmuta-
tion resulted in an MIC profile identical to that of AQ1 (Table 1). No
differences were seen in antibiotic susceptibility between the
Table 1. Antimicrobial susceptibility of representative mutants selected after biocide exposure
Selective biocide Sub-culturea
MIC (mg/L)b
NAL CIP CHL TET KAN TRI
Strain
SL1344 none 8 2 ,0.015 1 0.5 4 0.06
AQ1 AQAS 5 32 0.015 2 0.5 8 0.015
AQ2 AQAS 6 32 0.06 64 4 4 0.5
AQ4 AQAS 8 32 0.06 64 8 4 0.25
AQ5 AQAS 8 16 0.03 32 4 4 1
SK1 Superkill 2 32 0.12 64 8 2 0.5
SK3 Superkill 5 32 0.12 64 8 4 0.5
SK4 Superkill 6 16 0.06 16 4 4 1
SK7 Superkill 7 4 ,0.015 4 1 4 4
T2 Trigene 2 512 0.25 1 0.5 4 >1024
T3 Trigene 3 512 0.25 1 0.5 4 >1024
T6 Trigene 4 512 0.25 1 0.5 4 >1024
T9 Trigene 5 512 0.25 1 0.5 4 >1024
V2 Virkon 2 512 0.25 4 2 4 0.25
V4 Virkon 4 8 ,0.015 4 2 4 32
V6 Virkon 6 512 0.25 4 2 4 0.25
V8 Virkon 8 16 ,0.015 8 2 2 32
Site-directed mutants and complements
SL1344-rpoA NA NA 32 0.015 2 0.5 8 0.015
SL1344-zur NA NA 2 ,0.015 1 0.5 4 0.06
T2-pBAD-zur NA NA 512 0.25 1 0.5 4 >1024
AQ1-pBAD-rpoA NA NA 2 ,0.015 1 0.5 4 0.06
AQ2-pBAD-rpoA NA NA 32 0.06 64 4 4 0.5
NAL, nalidixic acid; CIP, ciprofloxacin; CHL, chloramphenicol; TET, tetracycline; KAN, kanamycin; TRI, triclosan; NA, not applicable.
aNumber of biocide exposures after which each strain was recovered.
bValues in bold indicate MICs ≥8-fold higher compared with SL1344.
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complemented strains and the mutants, suggesting the WT rpoA
allele is dominant to the mutant.
Biocide-selected mutants were as fit in vitro as the
parental strain
All of the mutants were able to grow at a similar rate to SL1334;
there were no statistically significant differences in generation
time of final culture densities achieved (Figure 2). Mutants
were also grown in competition with SL1344 after equal inocu-
lation into drug-free media in competitive index experiments
and the ratio of parent to mutant cells in the population was
monitored over time. To avoid unintended impacts on fitness,
mutants were differentiated from the parental strain on the
basis of resistance to drugs as identified in the original screen
rather than by using any additional markers. The average com-
petitive index of the mutants relative to SL1344 ranged from
0.94 to 1.05. Only the Trigenemutants that carried a gyrAmuta-
tion had a competitive index value that differed significantly
from SL1344 (0.94). There was no statistically significant differ-
ence between the other values for mutants compared with
SL1344 (Table 2).
To further examine the possible impact of the key genotypes
recovered after biocide exposure, a Biolog Phenomicroarray was
used to examine the ability of each strain to respire in various con-
centrations of a wide panel of drugs. These experiments showed
that mutation in rpoA, as selected after exposure to AQAS (AQ1),
conferred decreased susceptibility to the quinolones enoxacin and
nalidixic acid (this strain was 16-fold less susceptible to nalidixic
acid compared with SL1344; Table 1) and chloramphenicol
(Figure S1), but had increased susceptibility to 12 other com-
pounds (Table S2). Inactivation of ramR (as seen in AQ2, AQ4,
AQ5, SK1, SK3 and SK4) resulted in significantly increased respir-
ation in the presence of seven compounds, including DNA gyrase
and protein synthesis inhibitors, consistent with increased ex-
pression of MDR efflux pumps.35 Mutation in fabI was seen in
mutants recovered after exposure to both Trigene and Virkon
and in conjunction with mutations in gyrA and zur, or avtA,
respectively. Mutants with either combination were better
able to grow (measured by determining respiration rates) in the
presence of enoxacin and, in combination with gyrA, this was
extended to other quinolones. The fabI mutation in concert with
avtA did not provide a benefit when tested with any of the other
compounds in the Biolog.
Table 2. Mutations identified in the genome-sequenced mutants
Strain Gene Start positiona End positiona Reference Consensus Type of mutation Consequence Fitnessb
AQ1 hpaA 1152569 1152569 T G SNP F-V —
rpoA 3604893 3604893 T A SNP N294Y
AQ2 ramR 638142 638142 C T SNP G-D —
rpoA 3604893 3604893 T A SNP N294Y
AQ4 ramR 637844 637845 GT — deletion loss of function —
rpoA 3604893 3604893 T A SNP N294Y
AQ5 ramR 637844 637845 GT — deletion loss of function —
rpoA 3604893 3604893 T A SNP N294Y
SK1 ramR 637708 637719 GATCGCGCGCGG — deletion loss of function —
SK3 ramR 637708 637719 GATCGCGCGCGG — deletion loss of function —
SK4 ramR 637708 637719 GATCGCGCGCGG — deletion loss of function —
T2 fabI 1749266 1749266 G T SNP G93V 0.94
gyrA 2373804 2373804 T C SNP D87G
zur 4483329 4483329 — GC insertion loss of function
T3 fabI 1749266 1749266 G T SNP G93V 0.94
gyrA 2373804 2373804 T C SNP D87G
zur 4483329 4483329 — GC insertion loss of function
T6 fabI 1749266 1749266 G T SNP G93V 0.94
gyrA 2373804 2373804 T C SNP D87G
zur 4483329 4483329 — GC insertion loss of function
T9 fabI 1749266 1749266 G T SNP G93V 0.94
gyrA 2373804 2373804 T C SNP D87G
zur 4483329 4483329 — GC insertion loss of function
V2 gyrA 2373804 2373804 T C SNP D87G —
V4 fabI 1749266 1749266 G T SNP G93V —
avtA 3874433 3874433 A — deletion loss of function
V6 gyrA 2373803 2373803 C A SNP D87G —
V8 fabI 1749266 1749266 G T SNP G93V —
aStart and end positions relevant to SL1344 genome.
bCalculated in competition assays; ‘—’ indicates no significant difference compared with SL1344.
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Overall, these data indicate that exposure to biocides can
select mutant bacteria with altered susceptibility to a wide
range of antimicrobial agents.
Discussion
Many antimicrobial products are present in the environment at
low levels;25 here we showed that exposure to sub-lethal concen-
trations of all the biocides evaluated resulted in the selection of
antibiotic-resistant mutants. The antibiotic susceptibility pheno-
types of the mutants essentially fell into three major groups:
those that were MDR; those resistant to both quinolones and
triclosan; and those resistant to single agents. Surprisingly,
irrespective of the biocide, exposure resulted in mutations in
the same seven genes with mutations in certain genes selected
for by each biocide. Both AQAS and Superkill selected for MDR
mutants due to loss-of-function mutations in ramR that confer
de-repression of the AcrAB-TolC MDR efflux pump.35 In addition,
mutants with a substitution within GyrA at codon 87 were
also selected after exposure to two of the biocides (Trigene
and Virkon). This may initially seem surprising as this mutation
is classically associated with resistance to quinolone antibiotics.
However, we recently described a broad and generic benefit in
antimicrobial survival resulting from this mutation in Salmonella.30
This also explains why it has been favoured in separate biocide
exposure experiments, and this study extends the range of condi-
tions under which this mutation is beneficial.
Both the ramR and gyrA mutations recovered after biocide
exposure in vitro are commonly seen in clinical isolates of
Salmonella and other Enterobacteriaceae and therefore their
selection by biocide exposure is a concern. The mutations identi-
fied after exposure to diverse biocides with different mechanisms
of action indicate that there are convergent pathways to the sur-
vival of antimicrobial stress present in Enterobacteriaceae, and
both antibiotics and biocides can favour selection of identical
mutations in the same genes (Figure S2). Mutants emerged read-
ily after exposures to different biocides and were present after
only two exposures (sub-cultures) for three of the four biocides
tested. Once selected, mutants were stable; there was no evi-
dence of accumulation of multiple mutations after further biocide
exposure. Themutations selected had no great fitness costs when
tested in competitive index experiments against the parental
strain, and the occurrence of the ramR, gyrA and fabI mutations
in clinical and veterinary isolates confirms that they carry no pro-
hibitive fitness cost.30,32,36,37
The experimental design used maintained constant concen-
trations of biocides in each selection experiment (although poten-
tial degradation over each selection period was not measured),
and none of the mutants identified on the basis of antibiotic
tolerance showed any change in biocideMICs. These data indicate
that selection of resistance to the biocides themselves did not
occur under these conditions. The biocides used in this study are
highly toxic to bacteria; developing resistance to these com-
pounds would require multiple mutations and potentially a
much longer selective window would be needed to allow adapta-
tion to these compounds. However, it was evident that exposure
to sub-lethal concentrations of biocide exerted selective pressure
and mutations that promote bacterial survival also influenced
antibiotic susceptibility. Consistent with the findings after low-
level exposure in this study, we previously showed that bacteria
overexpressing efflux pumps are better able to survive high
concentrations of biocide.15 It has been demonstrated that
exposure to sub-lethal concentrations of antibiotics can exert
strong selective pressure and promote the rapid emergence
of mutants with better ability to grow under stress than WT
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Figure 2. Growth kinetics of selected mutant strains in comparison with SL1344. Growth kinetics were determined by measuring the OD at 600 nm of
cultures every 10 min over 16 h; data shown are the averages of eight replicate cultures for each strain.
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strains.9,10 Importantly, repeated exposure allows epistatic inter-
actions to be subjected to selective pressure; this may have
occurred in this study in the case of the rpoA and zur mutations.
The zur mutation alone contributed no major discernible pheno-
type when complemented or recreated in isolation in the parental
strain, but the rpoAmutation did result in decreased susceptibility
to nalidixic acid and increased susceptibility to triclosan; however,
this phenotype disappeared when complemented, suggesting
dominance of the parental allele. In Escherichia coli, RpoA is
known to interact with MarA and modulate its activity.38 In this
study rpoA mutations analogous to those described in E. coli
were found in concert with de-repression of ramA, encoding
RamA, a close homologue of MarA (ramA is present in most
Enterobacteriaceae, but not E. coli), so RpoA may also modulate
the activity of RamA. The mutation in zur resulted in loss of func-
tion of Zur, a predicted transcriptional repressor. The zur system is
involved in zinc uptake and mutations in zur were found in
mutants with changes in both fabI and gyrA; therefore, it is not
immediately clear how the resulting altered proteinsmay interact.
In the absence of a phenotype it is possible that the zurmutation
may be coincident and occurred in the relevant lineage before the
other mutations described appeared.
Legislation concerning biocides requires proof of efficacy
against target species at in-use concentrations; our data pre-
sented here indicate that sub-optimal concentrations of biocides
can select commonmutations that confer clinically relevant anti-
biotic resistance. The increasing accumulation of antimicrobial
compounds, including biocides, in the environment, food and peo-
ple represents a selective environment where microbes can be
exposed to persistent low levels of biocides. Mutants such as
those described in this manuscript could be selected in the
absence of, or prior to, antibiotic treatment. Therefore, the role
of environmental selection of antibiotic-resistant bacteria by
biocides should be considered by government agencies as policies
to control antibiotic-resistant bacteria are formulated and
implemented.
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